February 10th, 2022
Alkem licenses technology from Harvard University, aiming to treat ischemic injury and vascular diseases
Novel delivery of established growth and neurotropic factors enables local, sustained release for greater efficacy
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
February 10th, 2022
Novel delivery of established growth and neurotropic factors enables local, sustained release for greater efficacy
June 2nd, 2021
Development by New Orleans biotech company to enable studies of human fat tissue in vitro
January 15th, 2021
UTLP pools a subset of universities' intellectual property portfolios in the areas of connectivity, autonomous vehicles, and data applications
August 21st, 2020
Nucleic acid detection technology facilitates precision diagnostics
July 21st, 2020
Medical device company will pursue development of strong, biocompatible adhesive that could replace sutures and dental membranes